Anxiety and Mood Disorders
Download
Report
Transcript Anxiety and Mood Disorders
33 Happy Moments
•Write 33 Happy Moments!
•Background of “33 Happy Moments”
Chin Shengt'an's Thirty Three Happy Moments (17th
century), "moments when the spirit is inextricably tied up with the
senses." (Supposedly written while Chin was stuck in a temple for 10
days due to rain.)
Referred to in Lin Yutang’s The importance of living (1937) in
which Lin describes happiness as “sensuous” – meaning coming
from the senses. And that we recognize that we must
enjoy/honor the senses throughout our lives (30,000 mornings).
Relate this to Kathe’s talk
The continuums of
Mood Disorders
Unipolar - Bipolar
Chronic - Acute
Agitated – Slow
Neurotic – Psychotic
Depression symptoms
Diagnostic Exercise
What are the symptoms and diagnosis?
a. Case studies on the video clips
1.
VHS -- Program 8 (Mood Disorders)
2.
Faces DVD
Depression symptoms
• Cognitive
• Poor concentration, indecisiveness,
poor self-esteem, hopelessness,
suicidal thoughts, delusions,
memory problems
• Physiological and
Behavioral
• Sleep or appetite disturbances,
psychomotor problems, fatigue,
• Emotional
• Sadness,anhedonia (loss of interest
or pleasure in usual activities),
irritability
Duration
Number of
symptoms
Severity and diagnosis
Major Depression
Dysthymic Disorder
5 or more symptoms
including sadness or
loss of interest or
pleasure
3 or more symptoms
including depressed
mood
At least 2 weeks in
duration
At least 2 years in
duration
Clinical Description
Dysthymia
Dysthymia
Major
Depression
Feature Specifiers in Mood
Disorders
Melancholic
– Occurs within Major Depressive
Episode
– Near-complete absence of the
capacity for pleasure
– Strong biological component (e.g.,
psychomotor retardation; early
morning awakening; significant
anorexia)
Postpartum Onset
– Onset within four weeks following birth
– Spontaneous crying long after the usual duration
of “baby blues” (3-7 days postpartum)
– Lability of mood -- can be of a psychotic nature
– Suicidal ideation
Seasonal Pattern
– SAD
– Episodes during certain seasons
(usually winter)
– Typically characterized by anergy,
hypersomnia, overeating, weight
gain, and a craving for carbos
Major Features
Experience Both
– Manic Episodes
– Major Depressive Episodes
Roller Coaster of Mood
Mania and Hypomania
Elevated Mood
Decreased need for sleep
Grandiosity
Increased Activity
More talkative
Causes of Mood Disorders
Biological
Psychological
Socio-cultural
Biological Factors in
Mood Disorders
• Genetic contribution (heritable vulnerability in mood disorders).
Example: Bipolar
70
60
50
40
30
20
10
0
MZ twins
DZ twins
Sibs, parents,
children
Biological Second-degree
parents of BP
relatives
adoptees
General
population
Biological Factors in
Mood Disorders
• Neurotransmitters
•Monoamines – Dopamine, Norepinephrine, Serotonin
• Evidence
•Reserpine (hypotensive agent) breakdown of monoamine storage in
vesicles depression
•Antidepressants work on increasing MAs
•MAO Inhibitors
•SSRIs
•Decreased CSF levels of 5-HIAA in patients with severe depression
(and in completed suicides, post-mortem analysis)
Biological Factors in
Mood Disorders
• Endocrine Factors
•Stress and its neurochemical impacts
•Chronic glucocorticoid exposure monoamine depletion &
hippocampal cell atrophy (memory dysfunction)
Biological Factors in
Mood Disorders
• Brain factors
•Activity in the multi-nodal depression “circuit” (i.e.,
connections between and among the PFC, nucleus
accumbens, overactive anterior cingulate cortex [Cg25])
Deep Brain Stimulation for Treatment-Resistant Depression
Helen S. Mayberg, Andres M. Lozano, Valerie Voon, Heather E.
McNeely, David Seminowicz, Clement Hamani, Jason M. Schwalb,
and Sidney H. Kennedy
Neuron, Vol 45, 651-660, 03 March 2005
Biological Factors (in concert with behavioral factors)
in Mood Disorders
• Brain factors
• Effort-driven Rewards Center
• Nucleus accumbens-striatum-PFC (emotion-movementthinking)
• Lifestyle-depression link (hypothesis regarding increasing
depression with decreasing effort / use of our hands)
www.kellylambert.com
Stressful Life Events
Learned Helplessness
Rumination
Attributional Style / Negative
cognitions
Internal (“I blew it”)
Stable (“I’ll blow it again”)
Global (“”I blow it in tons of situations”)
CD Article (neighborhood
characteristics)
Social-cultural support
Treatments for Mood Disorders
• Men get depression DVD clips (treatment
section)
Biological Treatments for Mood
Disorders
•
•
•
•
•
•
•
Medication (prescribed and herbal)
Electroconvulsive therapy (ECT)
Repetitive transcranial magnetic stimulation
Vagus nerve stimulation
DBS
Light therapy
Exercise
See “Manufacturing Depression”
Medications
Tricyclic Antidepressants
MAOI’s
SSRI’s
Herbal (e.g., St. John’s Wort)
Lithium
Anti-convulsants
Psychological Treatments for
Depression
• Behavioral Therapy
– Increase positive reinforcers and decrease aversive events by teaching the
person new skills for managing interpersonal situations and the environment
• Cognitive-Behavioral Therapy
– Challenge distorted thinking and help the person learn more adaptive ways
of thinking and new behavioral skills
• Interpersonal
• Existential
• Psychodynamic Therapy
– Help the person gain insight to unconscious factors to facilitate change in
self-concept and behaviors
Cycle of Psychological Treatments
The risk of suicide and life interference can be reduced by shortening
the duration of MDEs with effective acute-phase treatments,
including pharmacotherapy, interpersonal psychotherapy, and
cognitive–behavioral therapy . We define acute-phase treatments
as those applied during an MDE with the goal of reducing
depressive symptoms and producing initial remission. Responders
to some acute-phase treatments (e.g., CT) may receive some
protection from relapse–recurrence , but prevalent relapse–
recurrence after successful antidepressant treatments has long been
recognized as a serious limitation of these interventions
Consequently, continuation-phase treatments (e.g.,
pharmacotherapy, interpersonal psychotherapy, CT) may be
applied to sustain remission of an MDE and reduce the probability
of relapse–recurrence. Continuation-phase treatments can match
the “modality” used in the acute phase or differ in modality
compared with the acute-phase treatment (e.g., acute-phase
pharmacotherapy followed by C-CT
Vittengl et al., JCCP, Vol 75(3), Jun 2007. pp. 475-488.